Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study

BACKGROUND: The purpose of this study was to investigate the effect of glibenclamide dose escalation on blood glucose and insulin in patients with poorly controlled type 2 diabetes. METHODS: Twenty-two subjects with type 2 diabetes were administered increasing doses (0, 2.5, 5, 10, and 20 mg/day) of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rambiritch, Virendra, Maharaj, Breminand, Naidoo, Poobalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983009/
https://www.ncbi.nlm.nih.gov/pubmed/24741335
http://dx.doi.org/10.2147/CPAA.S54809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983009/
https://www.ncbi.nlm.nih.gov/pubmed/24741335
http://dx.doi.org/10.2147/CPAA.S54809

Ejemplares similares